Chinese pharma imports pose national security risk, US Senate told
The current US dependence on China for critical medicines and pharmaceutical components presents a national security risk should China limit its pharmaceutical exports, industry stakeholders told a Senate hearing on Wednesday.The...To view the full article, register now.
Already a subscriber? Click here to view full article